COMMUNIQUÉS West-GlobeNewswire

Exalenz Announces Second Quarter 2018 Financial Results
31/08/2018
Second quarter 2018 revenue increased 53% to $3.4 million, compared with $2.2 million in same period in 2017 The Company estimates total revenues for 2018 to reach $13 -14 million, an increase of 37 – 47% over 2017, and [...]
Olainfarm’s Six Months Net Profit Reaches 5,78 million euros
31/08/2018
Unaudited Consolidated Income Statement of AS Olainfarm for first six months of 2018 shows that the sales of the Group have reached 61.8 million euros, which represents a slight decrease of 1% compared to the same [...]
Oncology Venture A/S: Publication of financial report for January - June 2018
31/08/2018
Oncology Venture A/S ("Oncology Venture", formerly Medical Prognosis Institute A/S) hereby publishes the financial report for the period of January - June 2018. The report is available as an attached document to this [...]
Cytori Therapeutics to Present at the 20th Annual Rodman & Renshaw Global Investment Conference
31/08/2018
Presentation on Thursday, September 06, 2018 at 09:10 AM Eastern Time SAN DIEGO, Aug. 31, 2018 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (NASDAQ: CYTX) announced today that it will present at the 20 th Annual Rodman [...]
Oncology Venture A/S establish a flexible loan facility of up to SEK 40 million
31/08/2018
Oncology Venture A/S ("Oncology Venture", formerly Medical Prognosis Institute A/S) hereby announces that the company has entered into a flexible loan agreement with Trention AB. Under the terms of the agreement, [...]
Genmab Announces European Marketing Authorization for DARZALEX® (daratumumab) for Front Line Multiple Myeloma
31/08/2018
Company Announcement DARZALEX approved in Europe in combination with bortezomib, melphalan and prednisone in patients with newly diagnosed multiple myeloma Approval follows positive opinion by European Committee for [...]
Zynerba Pharmaceuticals to Present at the H.C. Wainwright 20th Annual Global Investment Conference
31/08/2018
DEVON, Pa., Aug. 31, 2018 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric [...]
Portola Pharmaceuticals Submits Prior Approval Supplement to U.S. FDA for Large-Scale Generation 2 Andexxa Process
31/08/2018
SOUTH SAN FRANCISCO, Calif., Aug. 31, 2018 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. ® (Nasdaq:PTLA) today announced the submission of a prior approval supplement (PAS) to the U.S. Food and Drug Administration ( [...]
Selecta Biosciences Announces Presentation at the 20th Asia Pacific League of Associations for Rheumatology Congress (APLAR)
31/08/2018
WATERTOWN, Mass., Aug. 31, 2018 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (Nasdaq: SELB), a clinical-stage biopharmaceutical company focused on unlocking the full potential of biologic therapies by mitigating [...]
Rubius Therapeutics Reports Second Quarter 2018 Financial Results
31/08/2018
CAMBRIDGE, Mass., Aug. 31, 2018 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq: RUBY), a biotechnology company pioneering the development of a new class of ready-to-use cellular therapies, today reported second [...]
Altimmune Announces Initial Single-Dose Data from Its NasoShield Phase 1 Study
31/08/2018
Studies funded by BARDA GAITHERSBURG, Md., Aug. 31, 2018 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage immunotherapeutics company, today announced initial data from its Phase 1 study of NasoShield [...]
Atara Biotherapeutics to Participate at Two Upcoming Conferences
31/08/2018
SOUTH SAN FRANCISCO, Calif., Aug. 31, 2018 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq:ATRA), a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with [...]
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 juillet 2018
31/08/2018
Communiqué de presse Villepinte, le 31 août 2018 DECLARATION RELATIVE AU NOMBRE DE DROITS DE VOTE ET D'ACTIONS COMPOSANT LE CAPITAL DE LA SOCIETE En application de l'article L. 233-8 II du code de commerce et de l' [...]
Myriad Genetics to Present at the 2018 Morgan Stanley Global Healthcare Conference
31/08/2018
SALT LAKE CITY, Aug. 31, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and personalized medicine, announced today that Mark C. Capone, president and CEO, is scheduled [...]
Midatech Announces Interim Results from Proof of Concept Exploratory Study for its MTD201 Q-Octreotide Programme and Q-Sphera™ Microsphere Technology
31/08/2018
31 August 2018 Midatech Pharma PLC ("Midatech" or the "Company") Midatech Announces Interim Results from Proof of Concept Exploratory Study for its MTD201 Q-Octreotide Programme and Q-Sphera™ Microsphere Technology [...]
Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2018
31/08/2018
CRANBURY, N.J., Aug. 31, 2018 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced upcoming presentations at two investor conferences in September. Bradley Campbell, President and Chief Operating [...]
Cerecor CEO to Present at the H.C. Wainwright Global Investment Conference
31/08/2018
BALTIMORE, Aug. 31, 2018 (GLOBE NEWSWIRE) -- Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on the near-term goal of becoming a leader in the U.S. pediatric market space, today announced that the [...]
Auxly Announces Completion of KGK Science Acquisition
31/08/2018
VANCOUVER, British Columbia, Aug. 31, 2018 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V - XLY) (OTCQX: CBWTF) (" Auxly " or the " Company ") is pleased to announce that, further to its press release issued on [...]
BeiGene Announces Acceptance of New Drug Application for Anti-PD-1 Antibody Tislelizumab in Hodgkin’s Lymphoma in China
31/08/2018
BEIJING, China, and CAMBRIDGE, Mass., Aug. 31, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative [...]

Pages